Listed

Rand Capital Corp: Form 10-Q for the period ended Sep 30, 2020

Filed with the SEC on Nov 6, 2020 and accepted by EDGAR at Nov 6, 2020, 08:00 ET.

Share

Management's discussion and analysis

As filed, 42,115 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

You should read the following discussion and analysis of our financial condition and results of operations in conjunction with the consolidated financial statements and related notes included elsewhere in this report. Historical results and percentage relationships among any amounts in the consolidated financial statements are not necessarily indicative of trends in operating results for any future periods.

FORWARD LOOKING STATEMENTS

Statements included in this Management’s Discussion and Analysis of Financial Condition and Results of Operations and elsewhere in this report that do not relate to present or historical conditions are “forward-looking statements” within the meaning of that term in Section 27A of the Securities Act of 1933, as amended, and in Section 21E of the Securities Exchange Act of 1934, as amended. Additional oral or written forward-looking statements may be made by us from time to time, and forward-looking statements may be included in documents that are filed with the Securities and Exchange Commission. Forward-looking statements involve risks and uncertainties that could cause our results or outcomes to differ materially from those expressed in the forward-looking statements. Forward-looking statements may include, without limitation, statements relating to our plans, strategies, objectives, expectations and intentions, including statements related to our investment strategies, the impact of COVID-19 on our portfolio companies, our intention to elect U.S. federal tax treatment as a RIC for the 2020 tax year and the associated impact of such election on payment of corporate level taxes by Rand and our liquidity and financial resources, and are intended to be made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as “believes,” “forecasts,” “intends,” “possible,” “expects,” “estimates,” “anticipates,” or “plans” and similar expressions are intended to identify forward-looking statements. Among the important factors on which such statements are based are assumptions concerning the scope of the impact of the COVID-19 pandemic and its specific impact on our portfolio companies, the state of the United States economy and the local markets in which our portfolio companies operate, the state of the securities markets in which the securities of our portfolio companies could be traded, liquidity within the United States financial markets, and inflation. Forward-looking statements are also subject to the risks and uncertainties described under the caption “Risk Factors” contained in Part II, Item 1A of this report and in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2019.

There may be other factors not identified that affect the accuracy of our forward-looking statements. Further, any forward-looking statement speaks only as of the date when it is made and, except as required by law, we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances. New factors emerge from time to time that may cause our business not to develop as we expect, and we cannot predict all of them.

Overview

We are an externally managed investment company that lends to and invests in lower middle market companies. Our investment objective is to generate current income and when also possible, capital appreciation, by targeting investment opportunities with favorable risk-adjusted returns.

We have elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). As a BDC, we are required to comply with certain regulatory requirements. Historically, we made the majority of our investments through our wholly-owned subsidiary, Rand Capital SBIC, Inc. (“Rand SBIC”), which operates as a small business investment company (“SBIC”) and has been licensed by the U.S. Small Business Administration (“SBA”) since 2002. With the capital raised in 2019, we now also have liquidity at Rand Capital Corporation, the parent company, with which to make investments.

In November 2019, Rand completed a stock sale transaction (the “Transaction”) with East Asset Management (“East”). The Transaction consisted of a $25 million investment in Rand by East, in exchange for approximately 8.3 million shares of Rand common stock. The consideration paid by East for the shares of Rand common stock was comprised of $15.5 million of cash and $9.5 million of portfolio assets. Concurrent with the closing of the transaction with East, Rand’s management and staff became employees of Rand Capital Management, LLC (“RCM”), a registered investment adviser that has been retained by Rand as its external investment adviser. In connection with retaining RCM as our investment adviser and administrator, Rand entered into an investment advisory and management agreement (the “Investment Management Agreement”) and an administration agreement (the “Administration Agreement”) with RCM. Pursuant to the terms of the Investment Management Agreement, Rand will pay RCM a base management fee and may pay an incentive fee if specified benchmarks are met.

We intend to elect U.S federal tax treatment as a regulated investment company (“RIC”) under subchapter M of the Internal Revenue Code of 1986, as amended. With the election, we generally will not be subject to corporate-level U.S. federal income taxes on any net ordinary income or capital gains that we timely distribute to our shareholders as dividends.

In connection with our RIC election, we paid a special dividend of $23.7 million, or approximately $1.62 per share on the Corporation’s common stock, par value $0.10 per shares (the “Common Stock”), to shareholders on May 11, 2020, which distributed all of our accumulated earnings and profits since our inception through 2019. The total amount of cash distributed to all shareholders, as part of the special dividend, was limited to $4.8 million, or 20% of the total special dividend that was paid. The remaining 80% of the special dividend was paid using approximately 8.6 million shares of Common Stock.

To maintain our RIC status, we need to meet specified source-of-income and asset diversification requirements and distribute annually to our shareholders at least 90% of our ordinary net income and realized net short-term capital gains in excess of realized net long-term capital losses, if any. Accordingly, our Board of Directors has expressed its intention to adopt a new dividend policy that may include regular cash dividends to shareholders going forward.

As a result of the Transaction and our intention to elect RIC status, we have changed our investment objectives and strategy. Our investment objective is to generate current income and, when possible, complement this current income with capital appreciation. As a result, our future investments will be made primarily in debt and loan instruments, as well as high yielding publicly traded equity instruments that provide income through dividends and relatively more liquidity than our private company investments.

SEC Order

On October 7, 2020, the Company, RCM and certain of their affiliates received exemptive relief from the SEC to permit the Company to co-invest in portfolio companies with certain other funds, including other BDCs and registered investment companies, managed by RCM and certain of its affiliates in a manner consistent with the Company’s investment objective, positions, policies, strategies and restrictions as well as regulatory requirements, subject to compliance with certain conditions (the “Order”). Pursuant to the Order, the Company is generally permitted to co-invest with affiliated funds if a “required majority” (as defined in Section 57(o) of the 1940 Act) of the Company’s independent directors makes certain conclusions in connection with a co-investment transaction, including that (1) the terms of the transaction, including the consideration to be paid, are reasonable and fair to the Company and its shareholders and do not involve overreaching in respect of the Company or its shareholders on the part of any person concerned and (2) the transaction is consistent with the interests of the Company’s shareholders and is consistent with the Company’s investment objective and strategies.

Outlook

At the end of the third quarter of 2020, we had $19.1 million in cash and cash equivalents available for future investments and expenses, a decrease of $6.7 million from the end of 2019. The decrease was primarily due to approximately $7.0 million in additional portfolio investments and approximately $4.8 million in cash distributed to our shareholders as part of the special dividend. This was partially offset by approximately $4.6 million of cash received during the nine months ended September 30, 2020 from a portfolio exit.

Since the outbreak of the COVID-19 pandemic, our investment adviser, Rand Capital Management (“RCM”), continues to engage in active discussions with the management teams of the companies within our portfolio regarding actions taken by them for the safety and welfare of their employees and their processes for phasing back to pre-COVID work environments. We also have been informed by RCM on the impact of the COVID-19 induced recession on the businesses of the portfolio companies and the actions the portfolio companies have taken and are taking to adapt to changes in demand, both increased and decreased, depending upon the portfolio company. Most of our portfolio companies that qualified, have applied for, and received federal loans under the Paycheck Protection Program and, where applicable, are also applying for other federal support programs. While we do not know what the ultimate impact of the pandemic and the economic downturn will be on our portfolio companies, RCM is actively monitoring our portfolio companies, their liquidity and operational status.

Trends and Opportunities

We believe the combination of cash on hand, proceeds from portfolio exits, SBA leverage, and prospective investment income provide us the liquidity that enables us to add new investments to our portfolio and reinvest in existing portfolio companies that demonstrate continued growth potential. We are actively building a pipeline of investment opportunities in order to put our capital to work.

The following short and long-term trends provide us confidence in our ability to grow the Corporation:

  • We expect that well run businesses will require capital to grow and should be able to compete effectively given eager reception of new technologies and service concepts, regardless of the macroeconomic environment.
  • We continue to manage risk by investing with other investors, when possible.
  • We are involved with the governance and management of a majority of our portfolio companies, which enables us to support their operating and marketing efforts and facilitate their growth.
  • As our portfolio expands, we are able to better leverage our externalized management structure.
  • We believe receipt of cash and portfolio assets as consideration in the Transaction with East, as well as the establishment of RCM as our external investment adviser, broadens our potential pipeline of investment opportunities in order to build our portfolio, facilitate growth and reduce operating expenses as a percentage of portfolio assets. Strategically, we expect to advance our efforts to increase our income-producing investments to support a regular cash dividend for shareholders and complement our equity investments that drive capital appreciation.
  • We have sufficient cash to both invest in new opportunities and to repurchase shares. On April 22, 2020, our Board of Directors approved a new share repurchase plan, which authorizes the purchase of up to $1.5 million of our Common Stock through April 22, 2021 at prices per share of common stock no greater than the then current net asset value. During the nine months ending September 30, 2020, we purchased 3,397 shares at an average price of $11.18 per share.
  • RCM has advised the Corporation’s Board of Directors that Callodine Group, LLC (“Callodine”), an entity controlled by James Morrow, intends to acquire the controlling interest in RCM currently held by East (the “Adviser Change in Control”). As a result of the proposed Adviser Change in Control, Callodine will become the majority owner of RCM. Consummation of the Adviser Change in Control will result in an assignment and subsequent termination of the current Investment Management Agreement in accordance with the requirements of the 1940 Act. As a result, the Corporation’s Board of Directors has approved the Corporation’s entry into a new investment advisory and management agreement with RCM (the “New Advisory Agreement”) on October __, 2020, and has called a special meeting of shareholders for December 16, 2020 to seek shareholder approval of the New Advisory Agreement. Although the ownership of the Adviser will change in connection with the completion of the Adviser Change in Control, it is important to note that (i) RCM will continue to act as the investment adviser for the Corporation under the New Advisory Agreement following consummation of the Adviser Change in Control, (ii) there will be no change in terms under the New Advisory Agreement as compared to the terms of the current Investment Management Agreement, and (iii) the existing management team of RCM will not change as a result of the Adviser Change in Control.

Critical Accounting Policies

We prepare our consolidated financial statements in accordance with United States generally accepted accounting principles (GAAP), which require the use of estimates and assumptions that affect the reported amounts of assets and liabilities. A summary of our critical accounting policies can be found in our Annual Report on Form 10-K for the year ended December 31, 2019 under Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

Financial Condition

Overview:

September 30, 2020 December 31, 2019 (Decrease) Increase % (Decrease) Increase
Total assets $61,308,915 $64,791,449 $(3,482,534) (5.4)%
Total liabilities 11,358,762 11,162,933 195,829 1.8%
Net assets $49,950,153 $53,628,516 $(3,678,363) (6.9)%

Net asset value per share (NAV) was $19.32 at September 30, 2020 and $32.93 at December 31, 2019. The NAV as of December 31, 2019 was retroactively adjusted for the 1-for-9 reverse stock split effected in May 2020 by the Corporation.

Our gross outstanding SBA debentures at September 30, 2020 were $11,000,000 and they mature from 2022 through 2029. Cash and cash equivalents approximated 38% of net assets at September 30, 2020, as compared to 48% at December 31, 2019.

Composition of Our Investment Portfolio

Our financial condition is dependent on the success of our portfolio holdings. The following summarizes our investment portfolio at the dates indicated.

September 30, 2020 December 31, 2019 Increase (Decrease) % Increase (Decrease)
Investments, at cost $49,821,225 $44,619,463 $5,201,762 11.7%
Unrealized depreciation, net (8,138,704) (7,598,671) (540,033) 7.1%
Investments at fair value $41,682,521 $37,020,792 $4,661,729 12.6%

Our total investments at fair value, as determined by RCM and approved by our Board of Directors, approximated 83% of net assets at September 30, 2020 versus 69% of net assets at December 31, 2019.

With the completion of the Transaction, we changed our investment objectives and strategy. Our new investment objective is to generate current income and, when possible, complement this current income with capital appreciation. As a result, our future investments will be made primarily in higher yielding debt investments and may include public equity in other business development companies that provide income through dividends and relatively more liquidity than our private company investments.

The change in investments during the nine months ended September 30, 2020, at cost, is comprised of the following:

New investments: Cost Increase (Decrease)
Science and Medicine Group, Inc. (SMG) $1,900,000
SciAps Inc. (Sciaps) 1,500,000
Tilson Technology Management, Inc. (Tilson) 750,003
Golub Capital BDC, Inc. (Golub) 403,910
TCG BDC, Inc. (TCG) 376,996
PennantPark Investment Corporation (Pennantpark) 370,130
Apollo Investment Corporation (Apollo) 364,084
Owl Rock Capital Corporation (Owl Rock) 347,067
Ares Capital Corporation (Ares) 343,460
Barings BDC, Inc. (Barings) 333,352
FS KKR Capital Corp. (FS KKR) 338,980
Total of new investments 7,027,982
Other changes to investments:
AIKG LLC (Andretti) interest conversion 135,262
Mattison Avenue Holdings LLC (Mattison) interest conversion 79,819
Filterworks Acquisition USA, LLC (Filterworks) interest conversion 35,229
HDI Acquisition LLC (Hilton Displays) interest conversion 19,117
Microcision LLC (Microcision) OID amortization 16,498
Genicon Inc. (Genicon) OID amortization 15,804
GoNoodle, Inc. (GoNoodle) interest conversion 11,297
Sciaps OID amortization 6,250
Total of other changes to investments 319,276
Investments repaid, sold, liquidated or converted:
Outmatch Holdings, LLC (Outmatch) stock sale (2,145,496)
Total of investments repaid, sold, liquidated or converted (2,145,496)
Net change in investments, at cost $5,201,762

Results of Operations

Comparison of the three months ended September 30, 2020 to the three months ended September 30, 2019

Investment Income

Three months ended September 30, 2020 Three months ended September 30, 2019 Increase (Decrease) % Increase (Decrease)
Interest from portfolio companies $634,874 $328,103 $306,771 93.5%
Interest from other investments 1,157 36,797 (35,640) (96.9)%
Dividend and other investment income 93,337 65,996 27,341 41.4%
Fee income 7,500 6,459 1,041 16.1%
Total investment income $736,868 $437,355 $299,513 68.5%

The total investment income that was received on a current basis during the three months ended September 30, 2020 was received from thirteen portfolio companies. This contrasts with the ten portfolio companies generating current income during the three months ended September 30, 2019.

Interest from portfolio companies – Interest from portfolio companies was approximately 94% higher during the three months ended September 30, 2020 versus the same period in 2019 due to the fact that we have more income-producing debt investments in the current year. As part of the contributed assets received from East at the completion of the Transaction in November 2019, we received debt instruments from Andretti, Filterworks, Hilton Displays and Mattison.

The following investments are on non-accrual status: BeetNPath, LLC (Beetnpath), G-TEC Natural Gas Systems (G-Tec) and a portion of the Mercantile Adjustment Bureau, LLC (Mercantile) outstanding loan balances.

Interest from other investments - The decrease in interest from other investments is due to lower interest rates received on our cash and cash equivalents during the three months ended September 30, 2020 versus the same period in 2019.

Dividend and other investment income - Dividend income is comprised of cash distributions from limited liability companies (LLCs) and corporations in which we have invested. Our investment agreements with certain LLCs require those LLCs to distribute funds to us for payment of income taxes on our allocable share of the LLC’s profits. These portfolio companies may also elect to make additional discretionary distributions. Dividend income will fluctuate based upon the profitability of these LLCs and corporations and the timing of the distributions. The dividend distributions for the respective periods were:

Three months ended September 30, 2020 Three months ended September 30, 2019
Owl Rock Corporation (Owl Rock) $23,400 $-
Apollo Investment Corporation (Apollo) 15,750 -
TCG BDC, Inc. (TCG) 14,800 -
Tilson Technology Management Inc. (Tilson) 13,125 13,125
Ares Capital Corporation (Ares) 10,800 -
Golub Capital BDC, Inc. (Golub) 9,062 -
Barings BDC, Inc. (Barings) 6,400 -
Carolina Skiff LLC (Carolina Skiff) - 52,871
Total dividend and other investment income $93,337 $65,996

Fee income - Fee income generally consists of the revenue associated with the amortization of financing fees charged to the portfolio companies upon successful closing of SBIC financings, income from portfolio company board attendance fees and other miscellaneous fees. The financing fees are amortized ratably over the life of the instrument associated with the fees. The unamortized fees are carried on the balance sheet under the line item “Deferred revenue.”

The income associated with the amortization of financing fees was $7,500 and $6,459 for the three months ended September 30, 2020 and 2019, respectively. There were no board fees for the three months ended September 30, 2020 or 2019.

Expenses

Three months ended September 30, 2020 Three months ended September 30, 2019 Decrease % Decrease
Total expenses $456,398 $530,539 $(74,141) (14.0)%

In November 2019, we completed a stock sale transaction with East and concurrently externalized the management of our portfolio to Rand Capital Management, LLC (RCM) as our external investment adviser and administrator. Our primary operating expenses now include the payment of fees to RCM under the Investment Management Agreement, and our allocable portion of overhead expenses and other administrative expenses under the Administration Agreement with RCM. Under the terms of the Investment Management Agreement, the compensation of the investment professionals of RCM and its staff, and the general office and overhead expenses incurred by RCM in maintaining its place of business, will be provided and paid for by RCM and not by us. We will be responsible for all other operating expenses, including those relating to:

(i) organization;
(ii) costs of calculating our net asset value (including the cost and expenses of any independent valuation firm);
(iii) expenses incurred by RCM payable to third parties, including agents, consultants or other advisors, in monitoring financial and legal affairs and in monitoring the our investments and performing due diligence on its prospective portfolio companies;
(iv) interest payable on debt, if any, incurred to finance our investments;
(v) offerings of our Common Stock and other securities;
(vi) investment advisory and management fees payable under the Investment Management Agreement, but excluding any fees payable to any Sub-Adviser;
(vii) administration fees payable under the Administration Agreement;
(viii) transfer agent and custodial fees;

42

(ix) federal and state registration fees;
(x) all costs of registration and listing our shares on any securities exchange;
(xi) federal, state and local taxes;
(xii) independent directors’ fees and expenses;
(xiii) costs of preparing and filing reports or other documents required by governmental bodies (including the SEC);
(xiv) costs of any reports, proxy statements or other notices to shareholders, including printing costs;
(xv) our allocable portion of the fidelity bond, directors and officers/errors and omissions liability insurance, and any other insurance premiums;
(xvi) direct costs and expenses of administration, including independent auditors and outside legal costs; and
(xvii) all other expenses incurred by us or RCM in connection with administering our business (including payments under the Administration Agreement based upon our allocable portion of the RCM’s overhead in performing its obligations under the Administration Agreement, including rent and the allocable portion of the cost of our chief financial officer and chief compliance officer and their respective staffs (including travel expenses))

Expenses decreased approximately $74,000 or 14% during the three months ended September 30, 2020 compared to the three months ended September 30, 2019. The decrease in operating expenses was primarily due to an approximately $36,000 or 42% decrease in stockholders and office operating expenses and a bad debt recovery of $24,000. Stockholders and office operating expenses were higher during the three months ended September 30, 2019 due to the fact that we held a special meeting of shareholders to approve all proposals related to the Transaction. The decrease can also be attributable to the absence of the salary and benefits expense in the three months ended September 30, 2020. The salary and benefit expense for the three months ended September 30, 2019 was approximately $222,000. These decreases were offset by the new base management fee payable to RCM that amounted to $152,438 during the three months ended September 30, 2020 and the increase of professional fees of approximately $58,000 during the three months ended September 30, 2020. There were no incentive fees earned by RCM for the three months ended September 30, 2020.

Realized Gain (Loss) on Investments

There were no realized gains or losses during the three months ended September 30, 2020 or September 30, 2019.

Change in Unrealized Depreciation of Investments

The coronavirus (COVID-19) pandemic is causing significant consequences around the globe, and we believe, based upon discussions with our portfolio companies’ management, that many of our portfolio companies are experiencing uncertainty and concern for their operations during this unprecedented time. We believe that it is too soon to know if there will be any temporary or permanent impairment to their values, or other significant impact on their businesses. RCM and our Board of Directors will continue to assess the consequences of COVID-19 on our portfolio companies and examine any changes in their valuations during the remainder of 2020.

Three months ended September 30, 2020 Three months ended September 30, 2019 Change
Change in unrealized depreciation of investments before income taxes $(17,947) $(3,597,129) $3,579,182

43

The change in unrealized depreciation, before income taxes, for the three months ended September 30, 2020 was comprised of the following:

Three months ended September 30, 2020
PennantPark Investment Corporation (Pennantpark) $(48,130)
Apollo Investment Corporation (Apollo) (37,450)
Barings BDC, Inc. (Barings) (13,485)
TCG BDC, Inc. (TCG) (9,530)
Owl Rock Capital Corporation (Owl Rock) (7,000)
Ares Capital Corporation (Ares) (5,310)
FS KKR Capital Corp. (FS KKR) 50,250
Golub Capital BDC, Inc. (Golub) 52,708
Total change in net unrealized depreciation of investments before income taxes $(17,947)

Apollo, Ares, Barings, FS KKR, Golub, Owl Rock, Pennantpark and TCG are all publicly traded stocks, and as such, are marked to market at the end of each quarter.

The change in unrealized depreciation, before income taxes, for the three months ended September 30, 2019 was comprised of the following:

Three months ended September 30, 2019
Rheonix, Inc. (Rheonix) $(1,500,000)
Genicon, Inc. (Genicon) (1,447,467)
Empire Genomics, LLC (Empire Genomics) (249,661)
KnowledgeVision Systems, Inc. (KnowledgeVision) (200,001)
SciAps, Inc. (Sciaps) (200,000)
Total change in net unrealized depreciation of investments, before income taxes $(3,597,129)

The valuations of our investments in Empire Genomics, Genicon, KnowledgeVision, Rheonix and Sciaps were decreased after we reviewed each of the portfolio company’s operations, commercial progress against their business plan, and past and projected financial condition and determined that a valuation adjustment was necessary. Some of these decreases in value may be recoverable following the completion of their respective future financings.

All of these value adjustments resulted from a review by the Corporation’s management prior to the completion of the Transaction and RCM management after the completion of the Transaction, using the guidance set forth by ASC 820 and our established valuation policy.

Net Increase in Net Assets from Operations

We account for our operations under GAAP for investment companies. The principal measure of our financial performance is “net increase in net assets from operations” on our consolidated statements of operations. For the three months ended September 30, 2020 and 2019, the net increase (decrease) in net assets from operations was $262,523 and ($2,878,888), respectively.

Comparison of the nine months ended September 30, 2020 to the nine months ended September 30, 2019

Investment Income

Nine months ended September 30, 2020 Nine months ended September 30, 2019 Increase (Decrease) % Increase (Decrease)
Interest from portfolio companies $1,741,261 $1,049,557 $691,704 65.9%
Interest from other investments 87,161 108,146 (20,985) (19.4)%
Dividend and other investment income 200,900 307,681 (106,781) (34.7)%
Fee income 17,917 274,387 (256,470) (93.5)%
Total investment income $2,047,239 $1,739,771 $307,468 17.7%

44

Interest from portfolio companies – Interest from portfolio companies was approximately 66% higher during the nine months ended September 30, 2020 versus the same period in 2019 due to the fact that we have more income-producing debt investments in the current year. As part of the contributed assets received from East at the completion of the Transaction in November 2019, we received debt instruments from Andretti, Filterworks, Hilton Displays and Mattison. In addition, we originated two loan instruments, during the current year, totaling $3.4 million from SciAps, Inc. and Science and Medicine Group, Inc.

The following investments are on non-accrual status: BeetNPath, LLC (Beetnpath), G-TEC Natural Gas Systems (G-Tec) and a portion of the Mercantile Adjustment Bureau, LLC (Mercantile) outstanding loan balances.

Interest from other investments - The decrease in interest from other investments is due to lower interest rates during the nine months ended September 30, 2020 versus the same period in 2019. This was partially offset by higher average cash balances during the nine months ended September 30, 2020 versus the same period in 2019.

Dividend and other investment income - Dividend income is comprised of cash distributions from corporations and limited liability companies (LLCs) in which we have invested. Our investment agreements with certain LLCs require those LLCs to distribute funds to us for payment of income taxes on our allocable share of the LLC’s profits. These portfolio companies may also elect to make additional discretionary distributions. Dividend income will fluctuate based upon the profitability of these corporations and LLCs and the timing of the distributions. The dividend distributions for the respective periods were:

Nine months ended September 30, 2020 Nine months ended September 30, 2019
Tilson $39,375 $36,833
Owl Rock 35,100 -
FS KKR 34,000 -
Apollo 31,500 -
Ares 21,600 -
Golub 18,125 -
TCG 14,800 -
Barings 6,400 -
Knoa Software, Inc. (Knoa) - 193,934
Carolina Skiff LLC (Carolina Skiff) - 76,914
Total dividend and other investment income $200,900 $307,681

Fee income - Fee income generally consists of the revenue associated with the amortization of financing fees charged to the portfolio companies upon successful closing of SBIC financings, income from portfolio company board attendance fees and other miscellaneous fees. The financing fees are amortized ratably over the life of the instrument associated with the fees. The unamortized fees are carried on the balance sheet under the line item “Deferred revenue.”

The income associated with the amortization of financing fees was $17,917 and $48,887 for the nine months ended September 30, 2020 and 2019, respectively. During the nine months ended September 30, 2019, we recognized a one-time fee of $225,000 in conjunction with the repayment of the eHealth loan instrument. The board fees were $500 for the nine months ended September 30, 2019. There were no board fees for the nine months ended September 30, 2020.

Expenses

Nine months ended September 30, 2020 Nine months ended September 30, 2019 Decrease % Decrease
Total expenses $1,448,710 $2,044,351 $(595,641) (29.1)%

Expenses decreased approximately $596,000 or 29% during the nine months ended September 30, 2020 compared to the nine months ended September 30, 2019. The decrease in operating expenses was primarily due to an approximately $249,000 or 53% decrease in stockholders and office operating expenses. Stockholders and office operating expenses were higher during the nine months ended September 30, 2019 due to the fact that we held a special meeting of shareholders to approve all proposals related to the Transaction during this period. The decrease in expense can also be attributed to the absence of salary and benefits expense during the nine months ended September 30, 2020. The salary and benefit expense for the nine months ended September 30, 2019 was approximately $688,000. These decreases were offset by the new base management fee payable to RCM during the nine months ended September 30, 2020 of $434,201. There were no incentive fees earned by RCM during the nine months ended September 30, 2020.

Because of our intention to elect RIC status as of January 1, 2020, a net deferred tax asset of $1,451,658 was eliminated in accordance with GAAP, resulting in deferred tax expense for the nine months ended September 30, 2020. In addition, certain portfolio investments, that generate non-qualifying income for a RIC, and their related deferred tax liabilities of $247,460, were contributed to blocker corporations in December 2019. These blocker corporations will be subject to federal and state income taxes.

Realized Gain (Loss) on Investments

Nine months ended September 30, 2020 Nine months ended September 30, 2019 Change
Realized gain (loss) on investments before income taxes $2,412,046 $(392,239) $2,804,285

During the nine months ended September 30, 2020, we realized a $2.3 million gain when we exited our investment in Outmatch as part of a strategic majority investment from Rubicon Technology Partners. We also received additional proceeds of approximately $57,000 from Microcision LLC (Microcision) related to the 2019 sale of our equity interest in Microcision and approximately $37,000 in additional gain from Advantage 24/7.

During the nine months ended September 30, 2019, we recognized a realized loss on our investment in SOMS Technologies, LLC after the company ceased doing business and a $40,500 gain on our investment in Advantage 24/7 LLC after the company converted their equity into a debt instrument. In addition, we received a final proceeds distribution of $39,893 from Gemcor II, LLC, a portfolio company we exited in 2016.

Change in Unrealized Depreciation of Investments

Nine months ended September 30, 2020 Nine months ended September 30, 2019 Change
Change in unrealized depreciation of investments before income taxes $(540,033) $(4,197,281) $3,657,248

46

The change in unrealized depreciation, before income taxes, for the nine months ended September 30, 2020 was comprised of the following:

Nine months ended September 30, 2020
Genicon, Inc. (Genicon) $(515,804)
Apollo (71,367)
Pennantpark (48,130)
Barings (13,485)
TCG (9,530)
Golub 6,923
Owl Rock 17,633
Ares 34,540
FS KKR 59,187
Total change in net unrealized depreciation of investments before income taxes $(540,033)

The valuation of our investment in Genicon was decreased after a review of their operations and financial condition.

Apollo, Ares, Barings, FS KKR, Golub, Owl Rock, Pennantpark and TCG are all publicly traded stocks, and as such, are marked to market at the end of each quarter.

The change in unrealized depreciation, before income taxes, for the nine months ended September 30, 2019 was comprised of the following:

Nine months ended September 30, 2019
Genicon $(2,200,047)
Rheonix (1,500,000)
SocialFlow, Inc. (Socialflow) (1,071,300)
Sciaps (585,000)
BeetNPath, LLC (Beetnpath) (523,904)
Empire Genomics (249,661)
KnowledgeVision (200,001)
Mercantile Adjustment Bureau, LLC (Mercantile) (200,000)
SOMS Technologies, LLC realized loss 472,632
Tilson Technology Management, Inc. (Tilson) 1,860,000
Total change in net unrealized depreciation of investments before income taxes $(4,197,281)

The valuations of our investments in Beetnpath, Empire Genomics, KnowledgeVision, Mercantile, Rheonix, Sciaps, and Socialflow were decreased after we reviewed each of the portfolio company’s operations, commercial progress against their business plan, and past and projected financial condition and determined that a valuation adjustment was necessary.

Our valuation of Genicon was decreased due to a then recent round of financing and after a review of their financial condition.

In accordance with our valuation policy, we increased the value of our holdings in Tilson based on a significant equity financing during the first quarter of 2019 with a sophisticated new non-strategic outside investor at a higher valuation than their prior financing round valuation.

We recognized a realized loss on our investment in SOMS during the nine months ended September 30, 2019.

All of these value adjustments resulted from a review by our investment advisor, RCM, during the nine months ended September 30, 2020 and our management during the nine months ended September 30, 2019, using the guidance set forth by ASC 820 and our established valuation policy.

Net Increase (Decrease) in Net Assets from Operations

We account for our operations under GAAP for investment companies. The principal measure of our financial performance is “net increase (decrease) in net assets from operations” on our consolidated statements of operations. For the nine months ended September 30, 2020 and 2019, the net increase (decrease) in net assets from operations was $1,116,231 and ($3,771,022), respectively.

Liquidity and Capital Resources

With the completion of the Transaction with East, we changed our investment objectives and strategy. Previously, our principal investment objective was to achieve long-term capital appreciation on our equity investments while maintaining a current cash flow from debenture and pass-through equity instruments to fund expenses. With the intention to elect U.S. federal tax treatment as a RIC, we will be required to distribute at least 90% of our qualified net investment income in the form of a dividend, and our new investment objective is to maximize total return to our shareholders with current income combined with capital appreciation. As a result, our recent and future investments will be made primarily in yield generating investments and may include related equity options, such as warrants or preferred equity.

As of September 30, 2020, our total liquidity consisted of approximately $19,100,000 in cash and cash equivalents. In addition, we had an outstanding SBA leverage commitment of $3,000,000.

Net cash used in operating activities has averaged approximately $72,000 over the last three years. The cash used for investments in portfolio companies has averaged approximately $3,200,000 over the last three years. We will generally use cash to fund our operating expenses, invest in portfolio companies, pay dividends and repurchase shares. We anticipate that we will continue to exit investments and shift our portfolio to income producing investments. However, the timing of liquidation events within the portfolio is difficult to project. Starting in 2022 (See Note 6 in the Notes to the Consolidated Financial Statements), our outstanding SBA debt begins to mature and this will require us to identify sources of future funding if liquidation of investments is not sufficient to fund operations and repay the SBA debt obligation.

We believe that the cash on hand at September 30, 2020, the undrawn SBA leverage commitment and the scheduled interest payments on our portfolio investments will be sufficient to meet our cash needs throughout 2020. We continue to pursue current income and distributions from portfolio companies to increase the liquidity available for new investments, operating expenses, dividends and future SBA debenture obligations.

Our ongoing liquidity is tied to the performance of our portfolio companies and, as such, it may be affected going forward based on the impact of the COVID-19 pandemic and its lasting impact on the capital markets, our portfolio companies, and the U.S. economy in general.

Market risk

As filed, 1,868 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Our investment activities contain elements of risk. Our investment portfolio consists of equity and debt securities in private companies and is subject to valuation risk. Because there is typically no public market for the equity and debt securities in which we invest, the valuation of the equity interests in the portfolio is stated at “fair value” as determined in good faith by RCM and approved by our Board of Directors. This is in accordance with our investment valuation policy (see the discussion of valuation policy contained in “Note 3. Investments” in the consolidated financial statements contained in Item 1 of this report, which is hereby incorporated herein by reference.) In the absence of readily ascertainable market values, the estimated value of investments in our portfolio may differ significantly from the values that would be placed on such investments in our portfolio if a ready market for the investments existed. Any changes in valuation are recorded on the consolidated statement of operations as “Net change in unrealized depreciation on investments.”

At times, a portion of our portfolio may include, and does currently include, marketable securities traded in the over-the-counter market or on other stock markets. In addition, there may be a portion of the portfolio for which no regular trading market exists. In order to realize the full value of a security, the market must trade in an orderly fashion or a willing purchaser must be available when a sale is to be made. Should an economic or other event occur that would not allow markets to trade in an orderly fashion, we may not be able to realize the fair value of our marketable investments or other investments in a timely manner.

As of September 30, 2020, we did not have any off-balance sheet arrangements or hedging or similar derivative financial instrument investments.

Controls and procedures

As filed, 1,373 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Disclosure Controls and Procedures. The Corporation maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that this information is accumulated and communicated to management, including the Chief Executive Officer and the Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. The Chief Executive Officer and the Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of the Corporation’s disclosure controls and procedures as of September 30, 2020. Based on the evaluation of these disclosure controls and procedures, the Chief Executive Officer and Chief Financial Officer concluded that the Corporation’s controls and procedures were effective as of September 30, 2020.

Changes in Internal Control over Financial Reporting. There have been no changes in our internal control over financial reporting during the Corporation’s most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Corporation’s internal control over financial reporting.

PART II.

OTHER INFORMATION

Risk factors

As filed, 6,399 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

In addition to the information provided under the heading “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2019, the Corporation identified the following risk and uncertainty that could materially affect our overall business, financial condition and operating results.

The recent COVID-19 outbreak was declared a pandemic by the World Health Organization on March 11, 2020 and has rapidly spread to the United States, and may negatively affect the operating results, financial conditions or liquidity of our portfolio companies, which may subsequently have a negative impact on our operating results and financial condition. In addition, the pandemic may also negatively impact RCM’s ability, on our behalf, to invest a significant portion of the net proceeds from the Transaction on acceptable terms or within a reasonable timeframe.

The global outbreak of COVID-19 (“coronavirus”) has led to severe disruptions in general economic activities as businesses and federal, state, and local governments take and have taken broad actions to mitigate this public health crisis, including restrictions on travel and the temporary closure of many corporate offices, retail stores, and manufacturing facilities and factories across the United States and the wider global community.

As a result, the business, operating results, financial condition and liquidity of our portfolio companies have been, and may continue to be, materially and adversely affected. The cumulative impact to our portfolio companies’ results from coronavirus will depend to a large extent on the duration and severity of coronavirus and the actions taken by authorities and other entities to contain coronavirus or treat its impact, all of which are beyond our control. Certain of our portfolio companies have had, and may continue to have, their operations temporarily shut down or significantly curtailed, which we believe will further exacerbate the impact of these events on those portfolio companies. In addition, even if our portfolio companies have availed themselves of loans from the Small Business Administration under the Paycheck Protection Program or the other assistance provided by U.S. federal and state governmental entities to mitigate the impacts of coronavirus, certain of our portfolio companies have experienced, and may continue to experience, significant liquidity issues, which, in turn, may increasingly have negative effects the ability of those portfolio companies to repay principal and interests on outstanding loans and other debt instruments owed to the Corporation, including resulting in the Corporation having outstanding interest receivable balances owed to it and permitting certain portfolio companies to capitalize interest amounts owed to the Corporation. In addition, certain portfolio companies may not be able to continue as going concerns. In connection with the coronavirus pandemic we may be required to restructure certain of our investments on terms that are less favorable to us to avoid potential bankruptcies and other insolvency issues for our portfolio companies. A substantial negative impact to one or more of our portfolio companies as a result of coronavirus could have a material adverse effect on our business, financial condition and results of operations.

Furthermore, severe disruptions in general economic activities due to coronavirus may negatively affect RCM’s ability to invest a significant portion of the net proceeds from the Transaction on acceptable terms or within a reasonable timeframe. Delays by RCM in investing the net proceeds raised in the Transaction due to coronavirus may cause our performance to be worse than that of other fully invested BDCs or other lenders or investors pursuing comparable investment strategies. RCM may be unable to invest the net proceeds from the Transaction on acceptable terms during and after this pandemic, which could harm our financial condition and operating results. We anticipate that, depending on market conditions, it may take RCM a substantial period of time to invest substantially all of the net proceeds from the Transaction in securities meeting our investment objectives. This period may be further lengthened due to the impact of the coronavirus.

We may be subject to risks associated with our origination of, or investment in, covenant-lite loans to our portfolio companies.

We have originated or invested in, and may in the future originate or invest in, covenant-lite loans to our portfolio companies, which means the loan agreement or other debt instrument governing these debt obligations contains fewer maintenance covenants than other loan agreements or debt obligations, or no maintenance covenants, and may not include covenants that the Corporation could use to monitor the financial performance of the portfolio company borrower, including covenants based upon compliance with financial ratios, and declare a default under the loan agreement or other debt instrument if the specified covenants are breached. While these loans or other debt obligations to portfolio company borrowers may still contain other collateral protections, a covenant-lite loan may carry more risk than a covenant-heavy loan made by the same portfolio company borrower as it does not require this borrower to provide affirmation that certain specific financial tests have been satisfied on a routine basis, as is generally required under a covenant-heavy loan agreement or other debt instrument. Generally, covenant-lite loans or other debt instruments provide borrowers more freedom, which may negatively impact lenders because these covenants, if any, tend to be incurrence-based, meaning they are only tested and can only be breached following an affirmative action of the borrower, rather than by deterioration in the borrower’s financial condition. Should the financial condition of a portfolio company borrower begin to deteriorate, our investment in or origination of covenant-lite loans or other debt instruments to such portfolio company borrower may potentially reduce our ability to restructure such problematic loan and mitigate potential loss. As a result of our investment in or origination of covenant-lite loans, our exposure to losses may be increased, which could result in an adverse impact on the Corporation’s revenues, net income and NAV per share.

Source: SEC EDGAR, the filing index for accession 0001493152-20-020638. Last ingested by Listed: Nov 4, 2026, 08:48 ET. Listed shows no prices and gives no investment advice.